Opus Genetics, Inc.
NASDAQIRD heads into its May 20 earnings with short interest at its highest level in months and an unusual cluster of insider sells already logged — a charged setup for a $370M gene therapy micro-cap. Short interest has moved quickly and that is the story this week. SI % of FF jumped 52% over the past week to reach 7.5% of the free float — roughly 2.6 million shares short as of May 12…
IRD short interest surges 52% in one week, hitting 3.73% of float as biotech names face pressure.
Snapshot as of 28 Jun 2026
IRD heads into its May 20 earnings with short interest at its highest level in months and an unusual cluster of insider sells already logged — a charged setup for a $370M gene therapy micro-cap. Short interest has…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for IRD — free to start on ORTEX.
Sign up for free →Open IRD on ORTEXPulses are triggered by ORTEX's live data feeds. The full signal history, thresholds, and alerts are on ORTEX.
Live IRD data →